5[1]Lincoff AM,Harrington RA,Califf RM,et al.Management of patients with acute coronary syndromes in the United States by platelet glycoprotein Ⅱb/Ⅲa inhibition:Insights from the Platelet Glycoprotein Ⅱb/Ⅲa in Unstable Angina Receptor Suppression Using Int-egrilin (PURSUIT) trial.Circulation,2000,102:1093-1100.
6[2]Wong GC,Giugliano RP,Antman EM.Use of low-molecularweight heparins in the ma-nagement of acute coronary artery syndromes and percutaneous coronary intervention.JAMA,2003,289:331-342.
7[4]Zusman RM,Chesebro JH,Comerota A,et al.antiplatelet therapy in the prevention of ischemic vascular event:literature revew and evindence-basedguid elines for drug se-lection.Chin Cardiol,1999,22:559-573.
10[10]Breunwald E,Antman EM,Beasley JW,et al.ACC/AHA guideline for the management of patients with unstable angina and non-stsegment elevation myocardial infarction:a reportof the American heart association task force on practice guideline (Committee on the manngement of patents with unstable angina).J Am Coll Cardiol,2000,36:2976-2992.
